I would like to see, if we were to use the debt option, enough borrowed to cover four quarters, I definitely would hate to see the CR option, no matter how unlikely that may be.
Not sure another placement would be a good idea either, with the debt option that would give Admedus some much needed breathing space, any increase in income would be a super bonus in this situation, imo, that with capital on hand plus borrowings may turn the tide.
This is a laymans view, mine, seems to make sense to me, but I am not business brain.
That with the clarification on the immunotherapies division may do enough to create a postive sentiment/sp appreciation.
If these two actions still do not alter the current situation I seriously believe Admedus is in trouble!
- Forums
- ASX - By Stock
- AVR
- Answers from WP - a good read
Answers from WP - a good read, page-157
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M |
Open | High | Low | Value | Volume |
$12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 577 | $11.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.93 | 131 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 577 | 11.590 |
1 | 890 | 11.550 |
2 | 1080 | 11.500 |
1 | 400 | 11.360 |
1 | 500 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
11.930 | 131 | 1 |
12.250 | 250 | 1 |
12.500 | 1445 | 2 |
12.750 | 3000 | 1 |
12.850 | 1000 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online